These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16842085)

  • 1. Novel broad-spectrum thiourea non-nucleoside inhibitors for the prevention of mucosal HIV transmission.
    D'Cruz OJ; Uckun FM
    Curr HIV Res; 2006 Jul; 4(3):329-45. PubMed ID: 16842085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Uckun FM
    J Enzyme Inhib Med Chem; 2006 Aug; 21(4):329-50. PubMed ID: 17059165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.
    D'Cruz OJ; Uckun FM
    J Antimicrob Chemother; 2006 Mar; 57(3):411-23. PubMed ID: 16431862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase Inhibitors.
    Tabassum T; Azeem SM; Muwonge AN; Frey KM
    Curr HIV Res; 2020; 18(4):283-291. PubMed ID: 32493197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reserve transcriptase.
    Vig R; Mao C; Venkatachalam TK; Tuel-Ahlgren L; Sudbeck EA; Uckun FM
    Bioorg Med Chem; 1998 Oct; 6(10):1789-97. PubMed ID: 9839009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mao C; Vig R; Venkatachalam TK; Sudbeck EA; Uckun FM
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2213-8. PubMed ID: 9873515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Venkatachalam TK; Mao C; Qazi S; Uckun FM
    Biol Reprod; 2002 Dec; 67(6):1959-74. PubMed ID: 12444075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.
    Hsiou Y; Ding J; Das K; Clark AD; Boyer PL; Lewi P; Janssen PA; Kleim JP; Rösner M; Hughes SH; Arnold E
    J Mol Biol; 2001 Jun; 309(2):437-45. PubMed ID: 11371163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Balzarini J
    Curr Top Med Chem; 2004; 4(9):921-44. PubMed ID: 15134549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Biochem Pharmacol; 2000 Nov; 60(9):1251-65. PubMed ID: 11008119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent dual anti-HIV and spermicidal activities of novel oxovanadium(V) complexes with thiourea non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Dong Y; Uckun FM
    Biochem Biophys Res Commun; 2003 Mar; 302(2):253-64. PubMed ID: 12604339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design strategies of novel NNRTIs to overcome drug resistance.
    Zhan P; Liu X; Li Z; Pannecouque C; De Clercq E
    Curr Med Chem; 2009; 16(29):3903-17. PubMed ID: 19747133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel derivatives of phenethyl-5-bromopyridylthiourea and dihydroalkoxybenzyloxopyrimidine are dual-function spermicides with potent anti-human immunodeficiency virus activity.
    D'Cruz OJ; Uckun FM
    Biol Reprod; 1999 Jun; 60(6):1419-28. PubMed ID: 10330101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
    Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
    J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1593-8. PubMed ID: 10386942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.
    De Clercq E
    Farmaco; 1999; 54(1-2):26-45. PubMed ID: 10321027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel".
    Zhou Z; Liu T; Kang D; Huo Z; Wu G; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
    Org Biomol Chem; 2018 Feb; 16(6):1014-1028. PubMed ID: 29349445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds.
    Venkatachalam TK; Sudbeck EA; Mao C; Uckun FM
    Bioorg Med Chem Lett; 2001 Feb; 11(4):523-8. PubMed ID: 11229762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.